HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $249,778,254 | +73.8% | 2,194,888 | -5.5% | 0.06% | +57.9% |
Q3 2022 | $143,705,857 | -17.5% | 2,321,956 | +6.3% | 0.04% | -15.6% |
Q2 2022 | $174,251,034 | -30.0% | 2,184,692 | -7.7% | 0.04% | -16.7% |
Q1 2022 | $249,100,351 | -0.6% | 2,367,649 | +1.8% | 0.05% | +3.8% |
Q4 2021 | $250,526,000 | +7.9% | 2,324,851 | +9.7% | 0.05% | +2.0% |
Q3 2021 | $232,079,000 | +19.2% | 2,118,669 | +1.9% | 0.05% | +21.4% |
Q2 2021 | $194,675,000 | +13.1% | 2,078,973 | +11.1% | 0.04% | +7.7% |
Q1 2021 | $172,186,000 | +40.0% | 1,870,774 | +11.3% | 0.04% | +34.5% |
Q4 2020 | $122,990,000 | -14.0% | 1,681,337 | -8.6% | 0.03% | -23.7% |
Q3 2020 | $142,962,000 | +36.1% | 1,840,392 | -2.6% | 0.04% | +26.7% |
Q2 2020 | $105,027,000 | +68.5% | 1,889,660 | -10.2% | 0.03% | +36.4% |
Q1 2020 | $62,326,000 | -17.9% | 2,104,185 | +0.3% | 0.02% | +4.8% |
Q4 2019 | $75,955,000 | +26.5% | 2,098,191 | -4.9% | 0.02% | +16.7% |
Q3 2019 | $60,067,000 | – | 2,205,904 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,462,634 | $175,978,000 | 7.18% |
SCOPIA CAPITAL MANAGEMENT LP | 4,221,585 | $114,954,000 | 6.73% |
JW Asset Management, LLC | 270,775 | $7,373,000 | 6.49% |
KOPP INVESTMENT ADVISORS LLC | 104,462 | $2,845,000 | 5.23% |
1492 Capital Management LLC | 171,621 | $4,673,000 | 4.56% |
Avoro Capital Advisors LLC | 4,000,000 | $108,920,000 | 4.54% |
Paulson & Co. | 8,170,700 | $222,488,000 | 4.46% |
Rhenman & Partners Asset Management AB | 1,025,000 | $27,911,000 | 3.50% |
Redwood Investments, LLC | 1,376,066 | $37,470,000 | 2.88% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 218,000 | $5,938,000 | 2.74% |